Momenta Pharmaceuticals to Webcast at Two Upcoming Investor Conferences
October 31 2016 - 8:00AM
Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA), a biotechnology
company specializing in the characterization and engineering of
complex drugs, today announced that it will webcast its
presentation at two upcoming investor conferences.
25th Annual Credit Suisse Healthcare
ConferenceMonday, November 7, 2016 at 1:00 p.m. MST in
Scottsdale, AZ
Stifel 2016 Healthcare
ConferenceWednesday, November 16, 2016 at 11:45 a.m. EST
in New York, NY
The audio webcast of each presentation will be
available live on the “Investors” section of the company’s website
located at www.momentapharma.com. A replay of each
presentation will be posted on the Momenta website approximately
one hour after the event.
About MomentaMomenta
Pharmaceuticals is a biotechnology company specializing in the
detailed structural analysis of complex drugs and is headquartered
in Cambridge, MA. Momenta is applying its technology to
the development of generic versions of complex drugs, biosimilar
and potentially interchangeable biologics, and to the discovery and
development of novel therapeutics for autoimmune indications.
To receive additional information about Momenta,
please visit the website at www.momentapharma.com, which does
not form a part of this press release.
Our logo, trademarks, and service marks are the
property of Momenta Pharmaceuticals, Inc. All other trade names,
trademarks, or service marks are property of their respective
owners.
Contact:
Sarah Carmody
Momenta Pharmaceuticals
1-617-395-5189
IR@momentapharma.com
Momenta Pharmaceuticals (NASDAQ:MNTA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Momenta Pharmaceuticals (NASDAQ:MNTA)
Historical Stock Chart
From Apr 2023 to Apr 2024